Consensus Orthopedics Launches Orthopaedic Post-Surgical Wearable
Consensus Orthopedics launched TracPatch™, a wearable device for real-time, continuous post-surgical remote patient monitoring following total joint replacement. Mar 09, 2017
Second Patent for TheraCell Demineralized Bone Fiber Technology
TheraCell was awarded U.S. Patent Number 9,572,912, “Demineralized Bone Fibers having Controlled Geometry and Shapes and Methods Thereof,” its second U.S. patent for DBF™ technology. Mar 09, 2017
Positive Interim Data from Trial for BonyPid Antibiotic Eluting Bone Substitute
Interim results from study of BonyPid®-1000 bone substitute in the treatment of open tibial fractures indicate that the product met performance and safety endpoints in first patients at 6 months. Mar 09, 2017
Recruitment Status for ALLOB Delayed-Union Study
Bone Therapeutics completed recruitment of 16 patients in the Phase I/IIA delayed-union fracture study of ALLOB® allogeneic cell therapy product. Mar 09, 2017
Bioactive Glass Shown Effective Towards Antibiotic-resistant Bacteria
Studies of BonAlive® indicate that the naturally-antibacterial bioactive glass yields excellent results in the treatment of osteomyelitis, without the use of local antibiotics. Mar 08, 2017
Vertiflex Completes $40 Million Financing Round
Vertiflex will use funds from a US $40MM financing round to support U.S. commercial expansion of the Superion® Indirect Decompression System. Mar 08, 2017
Study Results: Vitrium Bioactive Glass in Ovine Spinal Fusion
Results from ovine study of Bio2 Technologies’ Vitrium bioactive glass demonstrated the device’s capability to support interbody fusion. Mar 08, 2017
Study Results: Use of CT Imaging in Post-op Assessment of Spine Surgery
Studies found that prevalence of CT imaging following complex spine surgery grew more than 2-fold from 6 months to 5 years, with patients averaging 2 scans during the period. Mar 08, 2017
Three New Ex-U.S. Distribution Partners for VTI
Vertebral Technologies appointed new distributors in Finland, Germany and Sweden to expand access to InterFuse® modular interbody fusion implants. Mar 07, 2017
Distribution Agreement for BoneScalpel in China
Misonix entered into an exclusive agreement with Weigao Orthopedic for distribution of the BoneScalpel in China, Hong Kong and Macau. Mar 07, 2017
